1. [Clinical tolerance of oral loading with elevated doses of amiodarone in a group of patients with heart failure]
- Author
-
G, Caramanno, P, Innocente, and F, Di Giovanna
- Subjects
Adult ,Aged, 80 and over ,Heart Failure ,Male ,Time Factors ,Administration, Oral ,Amiodarone ,Arrhythmias, Cardiac ,Drug Tolerance ,Middle Aged ,Echocardiography ,Humans ,Female ,Anti-Arrhythmia Agents ,Aged - Abstract
Amiodarone is a choice drug for the treatment of patients suffering from life-threatening hyperkinetic ventricular arrhythmias and depressed ventricular function. The drug is characterized by a remarkably long halflife and a delayed initial activity after oral administration of the usual loading levels. The aim of this study was to establish: -the clinical tolerance to elevated doses in patients with heart failure presenting complex, hyperkinetic ventricular arrhythmias; -the possibility to shorten hospitalization as a result of the oral loading; -whether this administration route would take less time to be efficacious. For this purpose, 30 patients with heart failure and complex, hyperkinetic ventricular arrhythmias were treated with 0.50 mg/kg body weight of amiodarone for three days and with 0.30 mg/kg on the 4th and 5th days, followed by a maintenance period of treatment with 200-400 mg daily. All patients underwent a 24-h Holter test before and after administration and an echocardiographic examination showing an average ejection fraction of approximately 30%. Amiodarone was clinically well tolerated; only 2 patients required discontinuation of therapy whereas, among the the remaining 28 patients, 2 cases of transient hypotension and 3 cases of gastroenteric disorders were observed. It was concluded that elevated doses of amiodarone were well tolerated, which allowed to reduce the loading period and, therefore, hospitalization.
- Published
- 1998